Stay updated on Fostamatinib in wAIHA Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in wAIHA Clinical Trial page.

Latest updates to the Fostamatinib in wAIHA Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.2 was applied. No substantive changes to the study details or page purpose are evident.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page adds Revision: v3.3.1 and removes Revision: v3.2.0; these are minor revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedRemoved the government funding lapse notice from the page, eliminating the external status guidance. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedExpanded the Contacts and Locations section with additional recruitment sites across multiple countries, increasing the total number of participating locations.SummaryDifference0.3%

- Check64 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check71 days agoChange Detected- Removed several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and - added a new Revision: v3.1.0.SummaryDifference0.4%

Stay in the know with updates to Fostamatinib in wAIHA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in wAIHA Clinical Trial page.